Baylor Genetics

Targeted reflex RNA sequencing can uncover answers beyond the genome.

In a retrospective analysis of more than 3,200 whole genome and whole exome sequencing cases, RNA sequencing led to variant reclassification in 42.2% of completed cases, resulting in a genetic or likely genetic diagnosis for 25 patients. Among cases with positive RNA-seq results, clinical management changed in 71% of cases, underscoring its potential clinical impact.

Join Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer, for the GenomeWeb-hosted webinar, When Genome Isn't Enough: Closing Rare Disease Gaps with RNA Sequencing, to learn how RNA sequencing can help improve diagnostic outcomes.

Register today: https://bit.ly/4bNfv9n

We're pleased to announce that Baylor Genetics is now integrated with Valley Children's Healthcare through Epic Aura.

This collaboration streamlines access to Baylor Genetics' testing services within existing clinical workflows, making test ordering and result delivery more efficient for providers. Together, we're helping expand access to Rapid Whole Genome Sequencing (rWGS) and Whole Genome Sequencing (WGS) for patients and families in rural and underserved communities.

Connect with Baylor Genetics about our Epic Aura Integration: https://www.baylorgenetics.com/connect-with-baylor-genetics-epic/

Join a team that's transforming how genomic insights are delivered.

We're looking for a Senior Software Engineer to help design and build the technology that powers our clinical laboratory operations and genomic testing services.

In this role, you'll lead development efforts, contribute to architectural decisions, mentor fellow engineers, and create scalable solutions that support patients, providers, and laboratory teams.

Apply today: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=5172d9be-d451-43da-b42a-f8c8d5d6d569

More data doesn't always mean more answers. Sometimes, a different layer of genomic insight is needed.

Join us on August 24 for "When the Genome isn't Enough: Closing Rare Disease Gaps with RNA Sequencing" to discover how RNA Sequencing can complement genome sequencing, helping clarify uncertain findings, and improve diagnostic yield for patients with rare genetic diseases.

We'll explore our recent manuscript on RNA-Seq with npj Genomic Medicine and discuss how Baylor Genetics is applying these insights through multimodal Whole Genome Sequencing in clinical care.

Register today: https://bit.ly/3RHhfdd

Every diagnosis has the potential to change a patient's path forward.

This Spinal Muscular Atrophy (SMA) Awareness Month, we recognize the power of genetic testing to help identify SMA earlier, inform clinical decision-making, and connect patients and families with the care and support they need.

Join us in raising awareness, advancing research, and expanding access to genetic testing. Together we can help improve outcomes for the SMA community.

Targeted reflex RNA Sequencing can uncover answers beyond the genome.

In a retrospective analysis of more than 3,200 Whole Genome and Whole Exome sequencing cases, RNA-Seq led to variant reclassification in 42% of completed cases, resulting in a genetic or likely genetic diagnosis for 25 patients. Among cases with positive RNA-Seq results, clinical management changed in 71% of cases, underscoring its potential clinical impact.

Join Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer, for the GenomeWeb-hosted webinar, When the Genome isn't Enough: Closing Rare Disease Gaps with RNA Sequencing, to learn how RNA-Seq can help improve diagnostic outcomes.

Register today: https://event.on24.com/wcc/r/5425767/A92063BE488169672B0928A34E813197?partnerref=baylor

Our values come to life through the people who live them.

This month, we're proud to recognize team members whose dedication, collaboration, innovation, and commitment to excellence make a meaningful impact across Baylor Genetics.

Join us in celebrating our Core Values honorees for the impact they make every day.

We're proud to announce that Baylor Genetics has received the Bronze Award for Technical Innovation of the Year at the 2026 Stevie® Awards for Technology Excellence for our Innovative Multimodal Solutions for Rare Disease Diagnostics.

This recognition reflects our commitment to advancing rare disease diagnostics with cutting-edge genomic technologies, including Whole Genome Sequencing, to help clinicians uncover answers for patients and families seeking a diagnosis.

Every innovation at Baylor Genetics is driven by our mission to shorten the diagnostic odyssey and improve patient care. We're honored to have our work recognized alongside some of today's leading technology innovations.

Learn more about the Stevie Awards for Technology Excellence: https://tech.stevieawards.com/

Every answer starts with a conversation.

Join us in recognizing Genetic Testing Action Day, a day dedicated to raising awareness about the power of genetic testing and helping providers and families take the next step toward answers.

Early conversations about genetic testing can help patients with unexplained symptoms or suspected rare diseases move closer to a diagnosis and more informed care decisions.

Help spread awareness, share your story, or encourage someone to ask about genetic testing. Together, we can help more people find the answers they deserve.